MRTX

Mirati Therapeutics Stock Price

216.8198
14.57 (7.2%)
Upgrade to Real-Time
Regular Market
216.8198
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Mirati Therapeutics Inc MRTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
14.57 7.2% 216.8198 13:10:48
Close Price Low Price High Price Open Price Previous Close
201.11 218.94 205.69 202.25
Bid Price Ask Price Spread News
216.27 216.74 0.47 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
9,900 654,810 $ 211.79 $ 138,681,581 585,863 66.01 - 218.94
Last Trade Time Type Quantity Stock Price Currency
13:10:52 5 $ 216.4684 USD

Mirati Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 9.66B 44.54M 38.94M $ 3.34M $ - -5.67 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Mirati Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MRTX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week183.93218.94177.80197.591,200,84632.8917.88%
1 Month169.39218.94162.05189.81548,90747.4328.0%
3 Months125.00218.94123.66165.87488,95991.8273.46%
6 Months91.40218.9480.36136.54458,360125.42137.22%
1 Year94.87218.9466.01112.79523,828121.95128.54%
3 Years12.85218.9412.5574.94554,611203.971,587.31%
5 Years34.57218.942.7055.86475,492182.25527.19%

Mirati Therapeutics Description

Mirati Therapeutics is an American biotechnology company. The company's medical focus is precision medicine: genetically targeted oncology therapeutics for selected patients. Mirati's drug candidates target specific genetic and epigenetic drivers of cancer.


Your Recent History
NASDAQ
MRTX
Mirati The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.